Endogenous stem and precursor cells for demyelinating diseases: an alternative for transplantation?
G D'Intino1, G Perretta, A Taglioni
1ASC-Lab, DIMORFIPA, University of Bologna, Italy.
Abstract:
Remyelination can be very effective in human. However, this process ultimately fails in multiple sclerosis (MS). In this paper, we discuss the possibility of stimulating endogenous oligodendrocyte precursors to participate in remyelination in experimental models (rat and primate Callithrix jacchus) of MS through thyroid hormone (TH) administration. TH is in fact known to be a key signal in brain development, oligodendrocyte development and myelin protein gene expression regulation.
More Related Videos
Related Concept Videos
iPS Cell Differentiation
EPS and iPS Cells in Disease Research
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...


